Tela Bio
在场
高管
查看带有其 19 名主要高管的组织结构图
Tela Bio 搜索最多的简介
- Antony Koblish, President and Chief Executive Officer and Director
- Federica O'Brien, Director
- Doug Evans, Chairman of the Board
高管在Tela Bio变化
- Jeffrey Blizard已作为Director加入公司 (新闻发布的2024六月5号).
- Peter Murphy, Chief Commercial Officer, 已经离开公司 (新闻发布的2024五月21号).
- Greg Firestone 曾任 Chief Business Officer, 现任 Chief Commercial Officer (新闻发布的2024五月21号).
创建提醒
跟踪 Tela Bio 的高管变动
生物技术
Tela Bio 拥有 2,316 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Tela Bio 的最新新闻稿
- TELA Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 11, 2020 | TELA Bio, Inc.
- TELA Bio Presents Additional Data from BRAVO Study of OviTex® for Ventral Hernia Repair | TELA Bio, Inc.
- TELA Bio to Participate at Upcoming Conferences | TELA Bio, Inc.
- TELA Bio Announces Second Quarter 2020 Financial Results | TELA Bio, Inc.
- TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference | TELA Bio, Inc.
- TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020 | TELA Bio, Inc.
- TELA Bio Announces Interim Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair | TELA Bio, Inc.
- TELA Bio Announces Closing of Public Offering of Common Stock | TELA Bio, Inc.
- TELA Bio Announces Pricing of Public Offering of Common Stock | TELA Bio, Inc.
- TELA Bio, Inc. to Join the Russell 2000® Index | TELA Bio, Inc.
- View more press releases Close
关于 Tela Bio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Antony Koblish 
